… , and the mobilization and differentiation of endothelial progenitor cells (EPCs) has been
shown to be important in this process. An elevated level of C-reactive protein (CRP) has …

Objective— C-reactive protein (CRP) has been suggested to participate in the development
of atherosclerosis, in part, by promoting endothelial dysfunction and impairing endothelial …

… This proatherogenic CRP was speculated to have a role in attenuating angiogenic functions
of human endothelial progenitor cells (EPCs), possibly impairing vascular regeneration and …

… effects were attenuated during RAGE protein expression … C-reactive protein (CRP) is a
prototypic marker of inflammation … (RAGE) expression in endothelial progenitor cells (EPCs) [3]. …

… C-reactive protein (CRP) is an acute phase reactant whose expression in the vascular wall,
in particular, in reactive plaque regions, and circulating levels increase in patients at high …

… numbers and activity of circulating endothelial progenitor cells (EPCs) correlate with severity
… Li SH, et al: C-reactive protein attenuates endothelial progenitor cell survival, differentiation, …

… Background—The acute-phase reactant C-reactive protein (CRP) is an important risk factor
for coronary heart disease. However, the possible effects of CRP on vascular cells are not …

… C-reactive protein are predictive of adverse cardiovascular events [23, 51, 71], decreased
numbers of circulating endothelial progenitor cells … the hypothesis that C-reactive protein might …

… tivity C-reactive protein (hs-CRP) in patients with diabetes. … C-reactive protein and other
markers of inflammation in the … A self-fulfilling prophecy: C-reactive protein attenuates nitric …

… Further studies are now indicated to determine whether CRP impairs the function of
endothelial progenitor cells in vivo, which are released from the bone marrow in an NO-dependent …